Symbols

NNNN

Anbio Biotechnology·NASDAQ

--(--)

8.02 / 10

Outperform

Analyst coverage is absent, but fund‑flow sentiment is excellent (8.02/10). Overall inflow ratio is 0.51 with positive trends for small, medium and extra‑large investors. Block and large investors show negative trends, yet net flow remains bullish.

Fund Flow Rating

Is money flowing into or out of NNNN?

NNNN holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.02/10 (Outperform).